Neuroimmunology Drug Development Summit, NIDD
Collaborate with your peers at the Neuroimmunology Drug Development Summit (NIDD), the first industry-focused networking forum to learn and share insight on how to successfully target chronic neuroinflammation as a universal therapeutic for various neurological diseases.
With an emphasis on neurodegeneration, NIDD will provide a discussion-led platform for you to discover the best strategies and most innovative technologies to aid your future neuroimmunological research.
Join the 70+ world class experts from AbbVie, Sanofi, Denali, Alector and Eisai to successfully guide the development of clinically efficacious therapeutics.
Conference + 2 Workshops: USD 4097.0,
Early Bird Price: USD 3897.0,
Conference + 1 Workshop: USD 3498.0,
Early Bird Price: USD 3298.0
Speakers: Sally Ishizaka (Eisai), Richard Ransohoff (Third Rock Ventures), Thomas Misko (AbbVie), Tarek Samad (Sanofi), Robert Nelson (MindImmune Therapeutics), Ajay Verma (United Neuroscience)
Time: 8:00 am - 5:00 pm
Registration Website: https://go.evvnt.com/330936-2?pid=4870
Submitted by Love Evvnt, Evvnt on Tuesday, 16 April 2019 at 8:00 AM
|Event Date: ||16 April 2019 - 18 April 2019
||Contact Person: ||Aarti Diwan
|Venue: ||Hyatt Regency Boston, 1 Avenue de Lafayette, Boston, 02111
||Tel: ||+1 617 455 4188
Category: Health Care & Medical
Brought to you by Scoopasia [http://scoopasia.com]